This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignees: Kenjockety Biotechnology, Inc., William Robert Arathoon Living Trust Dated August 29, 2016. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: William Robert Arathoon: Innovator in Cancer Treatment
Introduction
William Robert Arathoon is a notable inventor based in Tiburon, California. He has made significant contributions to the field of cancer treatment through his innovative research and development of multi-specific antibodies.
Latest Patents
Arathoon holds a patent for "Efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto." This patent provides multi-specific antibodies that target both a cellular efflux pump and a cancer-associated antigen. The invention includes pharmaceutical compositions, nucleic acids, recombinant expression vectors, cells, and kits that incorporate or encode these multi-specific antibodies. Additionally, the patent outlines methods for treating cancer by administering these antibodies to patients, as well as methods for generating the antibodies and related reagents.
Career Highlights
William Robert Arathoon is associated with the William Robert Arathoon Living Trust Dated August 29, 2016. His work focuses on advancing cancer treatment methodologies and improving patient outcomes through innovative antibody therapies.
Collaborations
Arathoon has collaborated with notable professionals in his field, including Evan Matthew Bishop and Raffaella Briante. These collaborations have contributed to the development and refinement of his innovative approaches to cancer treatment.
Conclusion
William Robert Arathoon's contributions to cancer treatment through his patented innovations highlight his commitment to improving healthcare. His work exemplifies the impact of inventive research in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile